This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 2013; 47: S2-6. doi: 10.1097/MCG.0b013e3182872f29MittalSEl-SeragHBEpidemiology of hepatocellular carcinoma: consider the populationJ Clin Gastroenterol201347S2610.1097/MCG.0b013e3182872f29Open DOISearch in Google Scholar
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 2019; 16: 589-604. doi: 10.1038/s41575-019-0186-yYangJDHainautPGoresGJAmadouAPlymothARobertsLRA global view of hepatocellular carcinoma: trends, risk, prevention and managementNat Rev Gastroenterol Hepatol20191658960410.1038/s41575-019-0186-yOpen DOISearch in Google Scholar
Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000; 47: 131-6. doi: 10.1136/gut.47.1.131DegosFChristidisCGanne-CarrieNFarmachidiJPDegottCGuettierCet alHepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and deathGut200047131610.1136/gut.47.1.131Open DOISearch in Google Scholar
Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: Target population for surveillance and diagnosis. Abdom Radiol 2018; 43: 13-25. doi: 10.1007/s00261-017-1209-1TangAHallouchOChernyakVKamayaASirlinCBEpidemiology of hepatocellular carcinoma: Target population for surveillance and diagnosisAbdom Radiol201843132510.1007/s00261-017-1209-1Open DOISearch in Google Scholar
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68: 723-50. doi: 10.1002/hep.29913MarreroJAKulikLMSirlinCBZhuAXFinnRSAbecassisMMet alDiagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver DiseasesHepatology2018687235010.1002/hep.29913Open DOISearch in Google Scholar
Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepato-cellular carcinoma. Semin Diagn Pathol 2017; 34: 153-9. doi: 10.1053/j.semdp.2016.12.011HartkeJJohnsonMGhabrilMThe diagnosis and treatment of hepato-cellular carcinomaSemin Diagn Pathol201734153910.1053/j.semdp.2016.12.011Open DOISearch in Google Scholar
Furlan A, Marin D, Cabassa P, Taibbi A, Brunelli E, Agnello F, et al. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines. Eur J Radiol 2012; 81: 2099-105. doi: 10.1016/j.ejrad.2011.07.010FurlanAMarinDCabassaPTaibbiABrunelliEAgnelloFet alEnhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelinesEur J Radiol201281209910510.1016/j.ejrad.2011.07.010Open DOISearch in Google Scholar
Harris PS, Hansen RM, Gray ME, Massoud OI, McGuire BM, Shoreibah MG. Hepatocellular carcinoma surveillance: an evidence-based approach. World J Gastroenterol 2019; 25: 1550-9. doi: 10.3748/wjg.v25.i13.1550HarrisPSHansenRMGrayMEMassoudOIMcGuireBMShoreibahMGHepatocellular carcinoma surveillance: an evidence-based approachWorld J Gastroenterol2019251550910.3748/wjg.v25.i13.1550Open DOISearch in Google Scholar
Anis M, Irshad A. Imaging of hepatocellular carcinoma: practical guide to differential diagnosis. Clin Liver Dis 2011; 15: 335-52. doi: 10.1016/j.cld.2011.03.014AnisMIrshadAImaging of hepatocellular carcinoma: practical guide to differential diagnosisClin Liver Dis2011153355210.1016/j.cld.2011.03.014Open DOISearch in Google Scholar
Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210. doi: 10.1016/j.ultrasmedbio.2012.09.002ClaudonMDietrichCFChoiBICosgroveDOKudoMNolsøeCPGuidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUSUltrasound Med Biol20133918721010.1016/j.ultrasmedbio.2012.09.002Open DOISearch in Google Scholar
Wilson SR, Lyshchik A, Piscaglia F, Cosgrove D, Jang HJ, Sirlin C, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol 2018; 43: 127-42. doi: 10.1007/s00261-017-1250-0WilsonSRLyshchikAPiscagliaFCosgroveDJangHJSirlinCet alCEUS LI-RADS: algorithm, implementation, and key differences from CT/MRIAbdom Radiol2018431274210.1007/s00261-017-1250-0Open DOISearch in Google Scholar
Jo PC, Jang H, Burns PN, Burak KW, Kim TK, Wilson SR. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do It. Radiology 2017; 282: 317-31. doi: 10.1148/radiol.2016151732JoPCJangHBurnsPNBurakKWKimTKWilsonSRIntegration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do ItRadiology20172823173110.1148/radiol.2016151732Open DOISearch in Google Scholar
Bruix J, Reig M, Rimola J, Forner A, Burrel M, Vilana R, et al. Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques. Hepatology 2011; 54: 2238-44. doi: 10.1002/hep.24670BruixJReigMRimolaJFornerABurrelMVilanaRet alClinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniquesHepatology20115422384410.1002/hep.24670Open DOISearch in Google Scholar
Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. Hepatology 2008; 47: 97-104. doi: 10.1002/hep.21966FornerAVilanaRAyusoCBianchiLSoléMAyusoJRet alDiffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic gradeHepatology2008479710410.1002/hep.21966Open DOISearch in Google Scholar
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236. doi: 10.1016/j.jhep.2018.03.019European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJ Hepatol20186918223610.1016/j.jhep.2018.03.019Open DOISearch in Google Scholar
Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors. Gastroenterology 2009; 136: 138-48. doi: 10.10153/j.gastro.2008.09.014LokASSeeffLBMorganTRdi BisceglieAMSterlingRKCurtoTMet alIncidence of hepatocellular carcinoma and associated risk factorsGastroenterology20091361384810.10153/j.gastro.2008.09.014Open DOISearch in Google Scholar
van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour J-F, Lammert F, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308: 2584-93. doi: 10.1001/jama.2012.144878vander Meer AJVeldtBJFeldJJWedemeyerHDufourJ-FLammertFet alAssociation between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosisJAMA201230825849310.1001/jama.2012.144878Open DOISearch in Google Scholar
Guarino M, Sessa A, Cossiga V, Morando F, Caporaso N, Morisco F. Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows. World J Gastroenterol 2018; 24: 2582-95. doi: 10.3478/wjg.v24.i24.2582GuarinoMSessaACossigaVMorandoFCaporasoNMoriscoFDirect-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadowsWorld J Gastroenterol20182425829510.3478/wjg.v24.i24.2582Open DOISearch in Google Scholar
Reig M, Marino Z, Perello C, Inarrairaegui M, Ribeiro A, Lens S, et al. Unexpected high rate of early tumor recurrence in patients with HCVrelated HCC undergoing interferon-free therapy. J Hepatol 2016; 65: 719-26. doi: 10.1016/j.jhep.2016.04.008ReigMMarinoZPerelloCInarrairaeguiMRibeiroALensSet alUnexpected high rate of early tumor recurrence in patients with HCVrelated HCC undergoing interferon-free therapyJ Hepatol2016657192610.1016/j.jhep.2016.04.008Open DOISearch in Google Scholar
Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCVrelated cirrhosis treated with direct-acting antivirals. J Hepatol 2016; 65: 727-33. doi: 10.1016/j.jhep.2016.06.015ContiFBuonfiglioliFScuteriACrespiCBolondiLCaraceniPet alEarly occurrence and recurrence of hepatocellular carcinoma in HCVrelated cirrhosis treated with direct-acting antiviralsJ Hepatol2016657273310.1016/j.jhep.2016.06.015Open DOISearch in Google Scholar
Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009; 44: 112-8. doi: 10.1007/s00535-008-2274-6KudoMMultistep human hepatocarcinogenesis: correlation of imaging with pathologyJ Gastroenterol200944112810.1007/s00535-008-2274-6Open DOISearch in Google Scholar
Matsui O, Kobayashi S, Sanada J, Kouda W, Ryu Y, Kozaka K, et al. Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 2011; 36: 264-72. doi: 10.1007/s00261-011-9685-1MatsuiOKobayashiSSanadaJKoudaWRyuYKozakaKet alHepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesisAbdom Imaging2011362647210.1007/s00261-011-9685-1Open DOISearch in Google Scholar
The International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009; 49: 658-64. doi: 10.1002/hep.22709The International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular NeoplasiaHepatology2009496586410.1002/hep.22709Open DOISearch in Google Scholar
Hytiroglou P, Park YN, Krinsky G, Theise ND. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 2007; 36: 867-87. doi: 10.1016/j.gtc.2007.08.010HytiroglouPParkYNKrinskyGTheiseNDHepatic precancerous lesions and small hepatocellular carcinomaGastroenterol Clin North Am2007368678710.1016/j.gtc.2007.08.010Open DOISearch in Google Scholar
Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22: 172-8. doi: 10.1016/0046-8177(91)90039-rSakamotoMHirohashiSShimosatoYEarly stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinomaHum Pathol199122172810.1016/0046-8177(91)90039-rOpen DOISearch in Google Scholar
Gupta M, Gabriel H, Miller FH. Role of imaging in surveillance and diagnosis of hepatocellular carcinoma. Gastroenterol Clin North Am 2018; 47: 585602. doi: 10.1016/j.gtc.2018.04.013GuptaMGabrielHMillerFHRole of imaging in surveillance and diagnosis of hepatocellular carcinomaGastroenterol Clin North Am20184758560210.1016/j.gtc.2018.04.013Open DOISearch in Google Scholar
Kudo M. Imaging blood flow characteristics of hepatocellular carcinoma. Oncology 2002; 62: 48-56. doi: 10.1159/000048276KudoMImaging blood flow characteristics of hepatocellular carcinomaOncology200262485610.1159/000048276Open DOISearch in Google Scholar
Takayasu K, Muramatsu Y, Mizuguchi Y, Moriyama N, Ojima H. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens. Intervirology 2004; 47: 199-208. doi: 10.1159/000078473TakayasuKMuramatsuYMizuguchiYMoriyamaNOjimaHImaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimensIntervirology20044719920810.1159/000078473Open DOISearch in Google Scholar
Tajima T, Honda H, Taguchi K, Asayama Y, Kuroiwa T, Yoshimitsu K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 2002; 178: 885-97. doi: 10.2214/ajr.178.4.1780885TajimaTHondaHTaguchiKAsayamaYKuroiwaTYoshimitsuKet alSequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlationAJR Am J Roentgenol20021788859710.2214/ajr.178.4.1780885Open DOISearch in Google Scholar
Kojiro M. ‘Nodule-in-nodule’ appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation. Intervirology 2004; 47: 179-83. doi: 10.1159/000078470KojiroM.‘Nodule-in-nodule’ appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiationIntervirology2004471798310.1159/000078470Open DOISearch in Google Scholar
Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 1999; 19: 12-8. doi: 10.1111/j.1478-3231.1999.tb00003.xNakashimaYNakashimaOHsiaCCKojiroMTaborEVascularization of small hepatocellular carcinomas: correlation with differentiationLiver19991912810.1111/j.1478-3231.1999.tb00003.xOpen DOISearch in Google Scholar
Kojiro M. Pathological diagnosis at early stage: reaching international consensus. Oncology 2010; 78: 31-5. doi: org/10.1159/000315227KojiroMPathological diagnosis at early stage: reaching international consensusOncology201078315doi: org/10.1159/00031522710.1159/000315227Search in Google Scholar
Inoue K, Takayama T, Higaki T, Watanabe Y, Makuuchi M. Clinical significance of early hepatocellular carcinoma. Liver Transpl 2004; 10: S16-9. doi: 10.1002/lt.20049InoueKTakayamaTHigakiTWatanabeYMakuuchiMClinical significance of early hepatocellular carcinomaLiver Transpl200410S16910.1002/lt.20049Open DOISearch in Google Scholar
Takayama T, Makuuchi M, Kojiro M, Lauwers GY, Adams RB, Wilson SR, et al. Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol 2008; 15: 972-8. doi: 10.1245/s10434-007-9685-0TakayamaTMakuuchiMKojiroMLauwersGYAdamsRBWilsonSRet alEarly hepatocellular carcinoma: pathology, imaging, and therapyAnn Surg Oncol200815972810.1245/s10434-007-9685-0Open DOISearch in Google Scholar
Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S, Yoshitoshi K, et al. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann Surg 2004; 239: 395-9. doi: 10.1097/01.sla.0000114215.03112.e0YamamotoMTakasakiKOtsuboTKatsuragawaHKatagiriSYoshitoshiKet alFavorable surgical outcomes in patients with early hepatocellular carcinomaAnn Surg2004239395910.1097/01.sla.0000114215.03112.e0Open DOISearch in Google Scholar
Kim TH, Kim SY, Tang A, Lee JM. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol 2019; 25: 245-63. doi: 10.3350/cmh.2018.0090KimTHKimSYTangALeeJMComparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 updateClin Mol Hepatol2019252456310.3350/cmh.2018.0090Open DOISearch in Google Scholar
Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, et al. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology 2013; 267: 776-86. doi: 10.1148/radiol.13120775ChoiJWLeeJMKimSJYoonJHBaekJHHanJKet alHepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarkerRadiology20132677768610.1148/radiol.13120775Open DOISearch in Google Scholar
Bartolozzi C, Battaglia V, Bargellini I, Bozzi E, Campani D, Pollina LE, et al. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 2013; 38: 290-6. doi: 10.1007/s00261-012-9952-9BartolozziCBattagliaVBargelliniIBozziECampaniDPollinaLEet alContrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted liversAbdom Imaging201338290610.1007/s00261-012-9952-9Open DOISearch in Google Scholar
Kim JH, Joo I, Lee JM. Atypical appearance of hepatocellular carcinoma and its mimickers: How to solve challenging cases using gadoxetic acid-enhanced liver magnetic resonance imaging. Korean J Radiol 2019; 20: 1019-41. doi: 10.3348/kjr.2018.0636KimJHJooILeeJMAtypical appearance of hepatocellular carcinoma and its mimickers: How to solve challenging cases using gadoxetic acid-enhanced liver magnetic resonance imagingKorean J Radiol20192010194110.3348/kjr.2018.0636Open DOISearch in Google Scholar
Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008; 247: 311-30. doi: 10.1148/radiol.2472061331WillattJMHussainHKAdusumilliSMarreroJAMR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversiesRadiology20082473113010.1148/radiol.2472061331Open DOISearch in Google Scholar
Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, Matsuda M, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology 2011; 261: 834-44. doi: 10.1148/radiol.11101840SanoKIchikawaTMotosugiUSouHMuhiAMMatsudaMet alImaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imagingRadiology20112618344410.1148/radiol.11101840Open DOISearch in Google Scholar
Robert M. A comparison of hepatopathologists’ and community pathologists’ review of liver biopsy specimens from patients with hepatitis C. Clin Gastroenterol Hepatol 2009; 7: 335-8. doi: 10.1016/j.cgh.2008.11.029RobertMA comparison of hepatopathologists’ and community pathologists’ review of liver biopsy specimens from patients with hepatitis CClin Gastroenterol Hepatol20097335810.1016/j.cgh.2008.11.029Open DOISearch in Google Scholar
Kim YK, Lee YH, Kim CS, Han YM. Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas. Eur J Radiol 2008; 67: 304-10. doi: 10.1016/j.ejrad.2007.07.001KimYKLeeYHKimCSHanYMAdded diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomasEur J Radiol2008673041010.1016/j.ejrad.2007.07.001Open DOISearch in Google Scholar
Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 2011; 55: 126-32. doi: 10.1016/j.jhep.2010.10.023PianaGTrinquartLMeskineNBarrauVBeersBVVilgrainVNew MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseasesJ Hepatol2011551263210.1016/j.jhep.2010.10.023Open DOISearch in Google Scholar
Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 2010; 255: 459-66. doi: 10.1148/radiol.10091388AhnSSKimMJLimJSHongHSChungYEChoiJYAdded value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinomaRadiology20102554596610.1148/radiol.10091388Open DOISearch in Google Scholar
Kim TK, Lee KH, Jang HJ, Haider MA, Jacks LM, Menezes RJ, et al. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology 2011; 259: 730-8. doi: 10.1148/radiol.11101549KimTKLeeKHJangHJHaiderMAJacksLMMenezesRJet alAnalysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinomaRadiology2011259730810.1148/radiol.11101549Open DOISearch in Google Scholar
Kierans AS, Makkar J, Guniganti P, Kierans AS, Makkar J, Guniganti P, et al. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) criteria for imaging diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 2019; 49: e205-e15. doi: 10.1002/jmri.26329KieransASMakkarJGunigantiPKieransASMakkarJGunigantiPet alValidation of Liver Imaging Reporting and Data System 2017 (LI-RADS) criteria for imaging diagnosis of hepatocellular carcinomaJ Magn Reson Imaging201949e205e1510.1002/jmri.26329Open DOISearch in Google Scholar
Chernyak V, Fowler KJ, Kamaya A, Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of hepatocellular carcinoma in at-risk patients. Radiology 2018; 289: 81630. doi: 10.1148/radiol.2018181494ChernyakVFowlerKJKamayaAChernyakVFowlerKJKamayaAet alLiver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of hepatocellular carcinoma in at-risk patientsRadiology20182898163010.1148/radiol.2018181494Open DOISearch in Google Scholar
Kamath A, Roudenko A, Hecht E, Sirlin C, Chernyak V, Fowler K, et al. CT/MR LI-RADS 2018: Clinical implications and management recommendations. Abdom Radiol 2019; 44: 1306-22. doi: 10.1007/s00261-018-1868-6KamathARoudenkoAHechtESirlinCChernyakVFowlerKet alCT/MR LI-RADS 2018: Clinical implications and management recommendationsAbdom Radiol20194413062210.1007/s00261-018-1868-6Open DOISearch in Google Scholar
Cannella R, Fowler KJ, Borhani AA, Minervini MI, Heller M, Furlan A. Common pitfalls when using the Liver Imaging Reporting and Data System (LI-RADS): lessons learned from a multi-year experience. Abdom Radiol 2019; 44: 43-53. doi: 10.1007/s00261-018-1720-zCannellaRFowlerKJBorhaniAAMinerviniMIHellerMFurlanACommon pitfalls when using the Liver Imaging Reporting and Data System (LI-RADS): lessons learned from a multi-year experienceAbdom Radiol201944435310.1007/s00261-018-1720-zOpen DOISearch in Google Scholar
Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 2009; 250: 435-43. doi: 10.1148/radiol.2501071702IshigamiKYoshimitsuKNishiharaYIrieHAsayamaYTajimaTet alHepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findingsRadiology20092504354310.1148/radiol.2501071702Open DOISearch in Google Scholar
Narsinh KH, Cui J, Papadatos D, Sirlin CB, Santillan CS. Hepatocarcinogenesis and LI-RADS. Abdom Radiol 2018; 43: 158-68. doi: 10.1007/s00261-017-1409-8NarsinhKHCuiJPapadatosDSirlinCBSantillanCSHepatocarcinogenesis and LI-RADSAbdom Radiol2018431586810.1007/s00261-017-1409-8Open DOISearch in Google Scholar
Cabibbo G, Enea M, Attanasio M, Bruix J, Craxi A, Camma C. A metaanalysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 2010; 51: 1274-83. doi: 10.1002/hep.23485CabibboGEneaMAttanasioMBruixJCraxiACammaCA metaanalysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinomaHepatology20105112748310.1002/hep.23485Open DOISearch in Google Scholar
Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707-16. doi: 10.1002/hep.20636MarreroJAFontanaRJBarratAAskariFConjeevaramHSSuGLet alPrognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohortHepatology2005417071610.1002/hep.20636Open DOISearch in Google Scholar
Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S, et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 2004; 40: 124-31. doi:10.1016/j.jhep.2003.09.027CilloUBassanelloMVitaleAGrigolettoFABurraPFagiuoliSet alThe critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?J Hepatol2004401243110.1016/j.jhep.2003.09.027Open DOISearch in Google Scholar
Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018; 391: 1301-14. doi: 10.1016/S0140-6736(18)30010-2FornerAReigMBruixJHepatocellular carcinomaLancet201839113011410.1016/S0140-6736(18)30010-2Open DOISearch in Google Scholar
Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, et al. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020; 55: 927-943. doi: 10.1007/s00535-020-01711-wMarascoGSerenariMRenzulliMAlemanniLVRossiniBPettinariIet alClinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatmentsJ Gastroenterol20205592794310.1007/s00535-020-01711-wOpen DOISearch in Google Scholar
Harimoto N, Yoshizumi T, Shimokawa M, Sakata K, Kimura K, Itoh S, et al. Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma. Hepatol Res 2016; 46:1247-55. doi: 10.1111/hepr.12674HarimotoNYoshizumiTShimokawaMSakataKKimuraKItohSet alSarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinomaHepatol Res20164612475510.1111/hepr.12674Open DOISearch in Google Scholar
Loosen SH, Schulze-Hagen M, Bruners P, Tacke F, Trautwein C, Kuhl C, et al. Sarcopenia is a negative prognostic factor in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies. Cancers 2019; 11: 1503. doi: 10.3390/cancers11101503.LoosenSHSchulze-HagenMBrunersPTackeFTrautweinCKuhlCet alSarcopenia is a negative prognostic factor in patients undergoing transarterial chemoembolization (TACE) for hepatic malignanciesCancers201911150310.3390/cancers11101503Open DOISearch in Google Scholar
Harimoto N, Shirabe K, Yamashita Y-I, Ikegami T, Yoshizumi T, Soejima Y, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013; 100: 1523-30. doi: 10.1002/bjs.9258HarimotoNShirabeKYamashitaY-IIkegamiTYoshizumiTSoejimaYet alSarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinomaBr J Surg201310015233010.1002/bjs.9258Open DOISearch in Google Scholar
Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015; 261: 1173-83. doi: 10.1097/SLA.0000000000000743VoronTTselikasLPietraszDPigneurFLaurentACompagnonPet alSarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinomaAnn Surg201526111738310.1097/SLA.0000000000000743Open DOISearch in Google Scholar
Kojiro M. Pathological evolution of early hepatocellular carcinoma. Oncology 2002; 62: 43-7. doi: 10.1159/000048275KojiroMPathological evolution of early hepatocellular carcinomaOncology20026243710.1159/000048275Open DOISearch in Google Scholar
Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007; 17: 2519-30. doi: 10.1007/s00330-007-0602-5BartolozziCCrocettiLLencioniRCioniDDellaPina CCampaniDBiliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast mediaEur Radiol20071725193010.1007/s00330-007-0602-5Open DOISearch in Google Scholar
Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol 2009; 193: 438-44. doi: 10.2214/AJR.08.1424NasuKKurokiYTsukamotoTNakajimaHMoriKMinamiMDiffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic gradeAJR Am J Roentgenol20091934384410.2214/AJR.08.1424Open DOISearch in Google Scholar
Cruite I, Schroeder M, Merkle EM, Sirlin CB. Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 2010; 195: 29-41. doi: 10.2214/AJR.10.4538CruiteISchroederMMerkleEMSirlinCBGadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liverAJR Am J Roentgenol2010195294110.2214/AJR.10.4538Open DOISearch in Google Scholar
Vasuri F, Golfieri R, Fiorentino M, Capizzi E, Renzulli M, Pinna AD, et al. OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. Virchows Arch 2011; 459: 141-6. doi: 10.1007/s00428-011-1099-5.VasuriFGolfieriRFiorentinoMCapizziERenzulliMPinnaADet alOATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantationVirchows Arch2011459141610.1007/s00428-011-1099-5Open DOISearch in Google Scholar
Golfieri R, Garzillo G, Ascanio S, Renzulli M. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines. Dig Dis 2014; 32: 696-704. doi: 10.1159/000368002GolfieriRGarzilloGAscanioSRenzulliMFocal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelinesDig Dis20143269670410.1159/000368002Open DOISearch in Google Scholar
Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006; 49: 138-51. doi: 10.1111/j.1365-2559.2006.02468.xDurnezAVerslypeCNevensFFeveryJAertsRPirenneJet alThe clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinomaA possible progenitor cell origin. Histopathology2006491385110.1111/j.1365-2559.2006.02468.xOpen DOISearch in Google Scholar
Vasuri F, Renzulli M, Fittipaldi S, Brocchi S, Clemente A, Cappabianca S, et al. Pathobiological and radiological approach for hepatocellular carcinoma subclassification. Sci Rep 2019; 9: 14749. doi: 10.1038/s41598-019-51303-9VasuriFRenzulliMFittipaldiSBrocchiSClementeACappabiancaSet alPathobiological and radiological approach for hepatocellular carcinoma subclassificationSci Rep201991474910.1038/s41598-019-51303-9Open DOISearch in Google Scholar
Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009; 44: 793-8. doi: 10.1007/s00535-009-0056-4NaritaMHatanoEArizonoSMiyagawa-HayashinoAIsodaHKitamuraKet alExpression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinomaJ Gastroenterol200944793810.1007/s00535-009-0056-4Open DOISearch in Google Scholar
Granito A, Galassi M, Piscaglia F, Romanini L, Lucidi V, Renzulli M, et al. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasivediagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 2013; 37: 355-63. doi: 10.1111/apt.12166GranitoAGalassiMPiscagliaFRomaniniLLucidiVRenzulliMet alImpact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasivediagnosis of small hepatocellular carcinoma: a prospective studyAliment Pharmacol Ther2013373556310.1111/apt.12166Open DOISearch in Google Scholar
Ichikawa T, Sano K, Morisaka H. Diagnosis of pathologically early HCC with EOB-MRI: experiences and current consensus. Liver Cancer 2014; 3: 97107. doi: 10.1159/000343865IchikawaTSanoKMorisakaHDiagnosis of pathologically early HCC with EOB-MRI: experiences and current consensusLiver Cancer201439710710.1159/000343865Open DOISearch in Google Scholar
Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis. Eur Radiol 2011; 21: 1233-42. doi: 10.1007/s00330-010-2030-1GolfieriRRenzulliMLucidiVCorcioniBTrevisaniFBolondiLContribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosisEur Radiol20112112334210.1007/s00330-010-2030-1Open DOISearch in Google Scholar
Renzulli M, Golfieri R, Bologna Liver Oncology Group (BLOG). Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver disease. J Gastroenterol Hepatol 2016; 31: 69-80. doi: 10.1111/jgh.13150RenzulliMGolfieriRBologna Liver Oncology Group (BLOG). Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver disease. J Gastroenterol Hepatol201631698010.1111/jgh.13150Open DOISearch in Google Scholar
Golfieri R, Grazioli L, Orlando E, Dormi A, Lucidi L, Corcioni B, et al. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration. J Magn Reson Imaging 2012; 36: 648-57. doi: 10.1002/jmri.23685GolfieriRGrazioliLOrlandoEDormiALucidiLCorcioniBet alWhich is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administrationJ Magn Reson Imaging2012366485710.1002/jmri.23685Open DOISearch in Google Scholar
Kim T, Murakami T, Hasuike Y, Gotoh M, Kato N, Takahashi M, et al. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 1997; 7: 683-8. doi: 10.1002/jmri.1880070413KimTMurakamiTHasuikeYGotohMKatoNTakahashiMet alExperimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPAJ Magn Reson Imaging19977683810.1002/jmri.1880070413Open DOISearch in Google Scholar
Taouli B. Diffusion-weighted MR imaging for liver lesion characterization: a critical look. Radiology 2012; 262: 378-80. doi: 10.1148/radiol.11112417TaouliBDiffusion-weighted MR imaging for liver lesion characterization: a critical lookRadiology20122623788010.1148/radiol.11112417Open DOISearch in Google Scholar
Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990; 336: 1150-3. doi: 10.1016/0140-6736(90)92768-dTakayamaTMakuuchiMHirohashiSSakamotoMOkazakiNTakayasuKet alMalignant transformation of adenomatous hyperplasia to hepatocellular carcinomaLancet19903361150310.1016/0140-6736(90)92768-dOpen DOISearch in Google Scholar
Roncalli M, Roz E, Coggi G, Di Rocco MG, Bossi P, Minola E, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 1999; 30: 1174-8. doi: 10.1002/hep.510300507RoncalliMRozECoggiGDiRocco MGBossiPMinolaEet alThe vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classificationHepatology1999301174810.1002/hep.510300507Open DOISearch in Google Scholar
Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-35. doi: 10.2214/AJR.06.1403KohDMCollinsDJDiffusion-weighted MRI in the body: applications and challenges in oncologyAJR Am J Roentgenol200718816223510.2214/AJR.06.1403Open DOISearch in Google Scholar
van den Bos IC, Hussain SM, Dwarkasing RS, Hop WCJ, Zondervan PE, de Man RA, et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 2007; 26: 1548-55. doi: 10.1002/jmri.21046vanden Bos ICHussainSMDwarkasingRSHopWCJZondervanPEdeMan RAet alMR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patternsJ Magn Reson Imaging20072615485510.1002/jmri.21046Open DOISearch in Google Scholar
Bruegel M, Holzapfel K, Gaa J, Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18: 477-85. doi: 10.1007/s00330-007-0785-9BruegelMHolzapfelKGaaJBruegelMHolzapfelKGaaJet alCharacterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging techniqueEur Radiol2008184778510.1007/s00330-007-0785-9Open DOISearch in Google Scholar
Lee MH, Kim SH, Park MJ, Park CK, Rhim H. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol 2011; 197: W868-75. doi: 10.2214/AJR.10.6237LeeMHKimSHParkMJParkCKRhimHGadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver diseaseAJR Am J Roentgenol2011197W8687510.2214/AJR.10.6237Open DOISearch in Google Scholar
Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R, et al. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 2009; 193: 1556-60. doi: 10.2214/AJR.09.2436SandrasegaranKAkisikFMLinCTahirBRajanJSaxenaRet alValue of diffusion-weighted MRI for assessing liver fibrosis and cirrhosisAJR Am J Roentgenol200919315566010.2214/AJR.09.2436Open DOISearch in Google Scholar
Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, et al. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 2012; 264: 761-70. doi: 10.1148/radiol.12112517ParkMJKimYKLeeMWLeeWJKimYSKimSHet alSmall hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patternsRadiology20122647617010.1148/radiol.12112517Open DOISearch in Google Scholar
Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992; 183: 819-25. doi: 10.1148/radiology.183.3.1316622KadoyaMMatsuiOTakashimaTNonomuraAHepatocellular carcinoma: correlation of MR imaging and histopathologic findingsRadiology19921838192510.1148/radiology.183.3.1316622Open DOISearch in Google Scholar
Channual S, Tan N, Siripongsakun S, Lassman C, Lu DS, Raman SS. Gadoxetate disodium-enhanced MRI to differentiate dysplastic nodules and grade of hepatocellular carcinoma: Correlation with histopathology. AJR Am J Roentgenol 2015; 205: 546-53. doi: 10.2214/AJR.14.12716ChannualSTanNSiripongsakunSLassmanCLuDSRamanSSGadoxetate disodium-enhanced MRI to differentiate dysplastic nodules and grade of hepatocellular carcinoma: Correlation with histopathologyAJR Am J Roentgenol20152055465310.2214/AJR.14.12716Open DOISearch in Google Scholar
Hwang J, Kim YK, Jeong WK, Choi D, Rhim H, Lee WJ. Nonhypervascular hypointense nodules at gadoxetic acid-enhanced MR imaging in chronic liver disease: Diffusion-weighted imaging for characterization. Radiology 2015; 276: 137-46. doi: 10.1148/radiol.15141350HwangJKimYKJeongWKChoiDRhimHLeeWJNonhypervascular hypointense nodules at gadoxetic acid-enhanced MR imaging in chronic liver disease: Diffusion-weighted imaging for characterizationRadiology20152761374610.1148/radiol.15141350Open DOISearch in Google Scholar
Kim T, Baron RL, Nalesnik MA. Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR Am J Roentgenol 2000; 175: 1121-5. doi: 10.2214/ajr.175.4.1751121KimTBaronRLNalesnikMAInfarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlationAJR Am J Roentgenol20001751121510.2214/ajr.175.4.1751121Open DOISearch in Google Scholar
Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Nakashima Y, Ikeno H, et al. Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriography. Cardiovasc Intervent Radiol 2011; 34: 81-6. doi: 10.1007/s00270-010-9835-9MiyayamaSYamashiroMOkudaMYoshieYNakashimaYIkenoHet alDetection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriographyCardiovasc Intervent Radiol20113481610.1007/s00270-010-9835-9Open DOISearch in Google Scholar
Santillan C, Fowler K, Kono Y, Chernyak V. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents. Abdom Radiol 2018; 43: 75-81. doi: 10.1007/s00261-017-1291-4SantillanCFowlerKKonoYChernyakVLI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agentsAbdom Radiol201843758110.1007/s00261-017-1291-4Open DOISearch in Google Scholar
Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD. Mosaic pattern of hepatocellular carcinoma: Histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 1996; 20: 337-42. doi: 10.1097/00004728-199605000-00001StevensWRGulinoSPBattsKPStephensDHJohnsonCDMosaic pattern of hepatocellular carcinoma: Histologic basis for a characteristic CT appearanceJ Comput Assist Tomogr1996203374210.1097/00004728-199605000-00001Open DOISearch in Google Scholar
Park HJ, Jang KM, Kang TW, Song KD, Kim SH, Kim YK, et al. Identification of imaging predictors discriminating different primary liver tumours in patients with chronic liver disease on gadoxetic acid-enhanced MRI: a classification tree analysis. Eur Radiol 2016; 26: 3102-11. doi: 10.1007/s00330-015-4136-yParkHJJangKMKangTWSongKDKimSHKimYKet alIdentification of imaging predictors discriminating different primary liver tumours in patients with chronic liver disease on gadoxetic acid-enhanced MRI: a classification tree analysisEur Radiol20162631021110.1007/s00330-015-4136-yOpen DOISearch in Google Scholar
Paik N, Sinn DH, Lee JH, Oh IS, Kim JH, Kang W, et al. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia. Liver Int 2018; 38: 68-75. doi: 10.1111/liv.13489PaikNSinnDHLeeJHOhISKimJHKangWet alNon-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremiaLiver Int201838687510.1111/liv.13489Open DOISearch in Google Scholar
Marasco G, Colecchia A, Silva G, Rossini B, Eusebi LH, Ravaioli F, et al. Non-invasive tests for the prediction of primary hepatocellular carcinoma. World J Gastroenterol 2020; 26: 3326-43. doi: 10.3748/wjg.v26.i24.3326MarascoGColecchiaASilvaGRossiniBEusebiLHRavaioliFet alNon-invasive tests for the prediction of primary hepatocellular carcinomaWorld J Gastroenterol20202633264310.3748/wjg.v26.i24.3326Open DOISearch in Google Scholar
Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 2010; 105: 599-609. doi: 10.1038/ajg.2009.654LeoniSPiscagliaFGolfieriRCamaggiVVidiliGPiniPet alThe impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteriaAm J Gastroenterol201010559960910.1038/ajg.2009.654Open DOISearch in Google Scholar
Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, et al. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology 2013; 267: 776-86. doi: 10.1148/radiol.13120775ChoiJWLeeJMKimSJYoonJHBaekJHHanJKet alHepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarkerRadiology20132677768610.1148/radiol.13120775Open DOISearch in Google Scholar
Kim YK, Lee WJ, Park MJ, Kim SH, Rhim H, Choi D. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology 2012; 265: 104-14. doi: 10.1148/radiol.12112649KimYKLeeWJParkMJKimSHRhimHChoiDHypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCCRadiology20122651041410.1148/radiol.12112649Open DOISearch in Google Scholar
Hyodo T, Murakami T, Imai Y, Okada M, Hori M, Kagawa Y, et al. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. Radiology 2013; 266: 480-90. doi: 10.1148/radiol.12112677HyodoTMurakamiTImaiYOkadaMHoriMKagawaYet alHypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinomaRadiology20132664809010.1148/radiol.12112677Open DOISearch in Google Scholar
Kumada T, Toyoda H, Tada T, Sone Y, Fujimori M, Ogawa S, et al. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol 2011; 197: 58-63. doi: 10.2214/AJR.10.5390KumadaTToyodaHTadaTSoneYFujimoriMOgawaSet alEvolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRIAJR Am J Roentgenol2011197586310.2214/AJR.10.5390Open DOISearch in Google Scholar
Yoon JH, Lee JM, Yang HK, Lee KB, Jang JJ, Han JK, et al. Non-hypervascular hypointense nodules ≥1 cm on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging in cirrhotic livers. Dig Dis 2014; 32: 678-89. doi: 10.1159/000368000YoonJHLeeJMYangHKLeeKBJangJJHanJKet alNon-hypervascular hypointense nodules ≥1 cm on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging in cirrhotic liversDig Dis2014326788910.1159/000368000Open DOISearch in Google Scholar
Motosugi U, Ichikawa T, Sano K, Motosugi U, Ichikawa T, Sano K, et al. Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease. J Magn Reson Imaging 2011; 34: 88-94. doi: 10.1002/jmri.22630MotosugiUIchikawaTSanoKMotosugiUIchikawaTSanoKet alOutcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver diseaseJ Magn Reson Imaging201134889410.1002/jmri.22630Open DOISearch in Google Scholar
Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 2007; 17: 2969-82. doi: 10.1007/s00330-007-0705-zEfremidisSCHytiroglouPMatsuiOEnhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challengesEur Radiol20071729698210.1007/s00330-007-0705-zOpen DOISearch in Google Scholar
Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, et al. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Radiology 2014; 271: 748-60. doi: 10.1148/radiol.14131996YuMHKimJHYoonJHKimHCChungJWHanJKet alSmall (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imagingRadiology20142717486010.1148/radiol.14131996Open DOISearch in Google Scholar
Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 2002; 178: 1327-34. doi: 10.2214/ajr.178.6.1781327JeongYYMitchellDGKamishimaTSmall (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implicationsAJR Am J Roentgenol200217813273410.2214/ajr.178.6.1781327Open DOISearch in Google Scholar
Holland AE, Hecht EM, Hahn WY, Holland AE, Hecht EM, Hahn WY, et al. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005; 237: 938-44. doi: 10.1148/radiol.2373041364HollandAEHechtEMHahnWYHollandAEHechtEMHahnWYet alImportance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liverRadiology20052379384410.1148/radiol.2373041364Open DOISearch in Google Scholar
Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, et al. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004; 230: 637-44. doi: 10.1148/radiol.2303020921HussainHKSyedINghiemHVJohnsonTDCarlosRCWeadockWJet alT2-weighted MR imaging in the assessment of cirrhotic liverRadiology20042306374410.1148/radiol.2303020921Open DOISearch in Google Scholar
Kim JE, Kim SH, Lee SJ, Rhim H. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 2011; 196: W758-65. doi: 10.2214/AJR.10.4394KimJEKimSHLeeSJRhimHHypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imagingAJR Am J Roentgenol2011196W7586510.2214/AJR.10.4394Open DOISearch in Google Scholar
Semelka RC, Brown ED, Ascher SM, Patt RH, Bagley AS, Li W, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994; 192: 401-6. doi: 10.1148/radiology.192.2.8029404SemelkaRCBrownEDAscherSMPattRHBagleyASLiWet alHepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR imagesRadiology1994192401610.1148/radiology.192.2.8029404Open DOISearch in Google Scholar
Kitao A, Zen Y, Matsui O, Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. Radiology 2010; 256: 817-26. doi: 10.1148/radiol.10092214KitaoAZenYMatsuiOKitaoAZenYMatsuiOet alHepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic featuresRadiology20102568172610.1148/radiol.10092214Open DOISearch in Google Scholar
Leonhardt M, Keiser M, Oswald S, Kühn J, Jia J, Grube M, et al. Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos 2010; 38: 1024-8. doi: 10.1124/dmd.110.032862LeonhardtMKeiserMOswaldSKühnJJiaJGrubeMet alHepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transportersDrug Metab Dispos2010381024810.1124/dmd.110.032862Open DOISearch in Google Scholar
Asayama Y, Tajima T, Nishie A, Ishigami K, Kakihara D, Nakayama T, et al. Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. Eur J Radiol 2011; 80: e243-8. doi: 10.1016/j.ejrad.2010.10.032AsayamaYTajimaTNishieAIshigamiKKakiharaDNakayamaTet alUptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile productionEur J Radiol201180e243810.1016/j.ejrad.2010.10.032Open DOISearch in Google Scholar
Grazioli L, Morana G, Caudana R, Benetti A, Portolani N, Talamini G, et al. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 2000; 35: 25-34. doi: 10.1097/00004424-200001000-00003]GrazioliLMoranaGCaudanaRBenettiAPortolaniNTalaminiGet alHepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findingsInvest Radiol200035253410.1097/00004424-200001000-00003]Open DOISearch in Google Scholar
Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol 2004; 39: 80-8. doi: 10.1097/01.rli.0000105331.11373.c0TsudaNKatoNMurayamaCNarazakiMYokawaTPotential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumorsInvest Radiol20043980810.1097/01.rli.0000105331.11373.c0Open DOISearch in Google Scholar
Vavricka SR, Jung D, Fried M, Grützner U, Meier PJ, Kullak-Ublick GA. The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3 beta in hepatocellular carcinoma. J Hepatol 2004; 40: 212-8. doi: 10.1016/j.jhep.2003.10.008VavrickaSRJungDFriedMGrütznerUMeierPJKullak-UblickGAThe human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3 beta in hepatocellular carcinomaJ Hepatol200440212810.1016/j.jhep.2003.10.008Open DOISearch in Google Scholar
Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, et al. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 2010; 255: 82433. doi: 10.1148/radiol.10091557TsuboyamaTOnishiHKimTAkitaHHoriMTatsumiMet alHepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulationRadiology20102558243310.1148/radiol.10091557Open DOISearch in Google Scholar
Kondo Y, Nakajima T. Pseudoglandular hepatocellular carcinoma. A morphogenetic study. Cancer 1987; 60: 1032-7. doi: 10.1002/1097-0142(19870901)60:5<1032::aid-cncr2820600518>3.0.co;2-kKondoYNakajimaTPseudoglandular hepatocellular carcinomaA morphogenetic study. Cancer1987601032710.1002/1097-0142(19870901)60:5<1032::aid-cncr2820600518>3.0.co;2-k10.1002/1097-0142(19870901)60:5<1032::AID-CNCR2820600518>3.0.CO;2-KSearch in Google Scholar
Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN. Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Eur J Radiol 2012; 81: 3877-82. doi: 10.1016/j.ejrad.2012.07.021KimJYKimMJKimKAJeongHTParkYNHyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological featuresEur J Radiol20128138778210.1016/j.ejrad.2012.07.021Open DOISearch in Google Scholar
Yoneda N, Matsui O, Kitao A, Kita R, Kozaka K, Koda W, et al. Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature. Jpn J Radiol 2013; 31: 480-90. doi: 10.1007/s11604-013-0224-6YonedaNMatsuiOKitaoAKitaRKozakaKKodaWet alHypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte natureJpn J Radiol2013314809010.1007/s11604-013-0224-6Open DOISearch in Google Scholar
Kitao A, Matsui O, Yoneda N, Kita R, Kozaka K, Kobayashi S, et al. Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid-enhanced MRI and focal nodular hyperplasia by CT and MRI. AJR Am J Roentgenol 2018; 211: 347-57. doi: 10.2214/AJR.17.19341KitaoAMatsuiOYonedaNKitaRKozakaKKobayashiSet alDifferentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid-enhanced MRI and focal nodular hyperplasia by CT and MRIAJR Am J Roentgenol20182113475710.2214/AJR.17.19341Open DOISearch in Google Scholar
Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, et al. Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 1999; 210: 443-50. doi: 10.1148/radiology.210.2.r99fe13443VilgrainVLewinMVonsCDenysAVallaDFlejouJFet alHepatic nodules in Budd–Chiari syndrome: imaging featuresRadiology19992104435010.1148/radiology.210.2.r99fe13443Open DOISearch in Google Scholar
Renzulli M, Lucidi V, Mosconi C, Quarneti C, Giampalma E, Golfieri R. Large regenerative nodules in a patient with Budd–Chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRI. Hepatobiliary Pancreat Dis Int 2011; 10: 439-42. doi: 10.1016/s1499-3872(11)60075-1RenzulliMLucidiVMosconiCQuarnetiCGiampalmaEGolfieriRLarge regenerative nodules in a patient with Budd–Chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRIHepatobiliary Pancreat Dis Int2011104394210.1016/s1499-3872(11)60075-1Open DOISearch in Google Scholar
